Prime Capital Investment Advisors LLC reduced its stake in Xylem Inc. (NYSE:XYL - Free Report) by 64.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,569 shares of the industrial products company's stock after selling 2,873 shares during the quarter. Prime Capital Investment Advisors LLC's holdings in Xylem were worth $203,000 at the end of the most recent reporting period.
Several other large investors have also recently bought and sold shares of XYL. Farther Finance Advisors LLC raised its holdings in Xylem by 30.4% in the 1st quarter. Farther Finance Advisors LLC now owns 1,797 shares of the industrial products company's stock valued at $215,000 after acquiring an additional 419 shares during the period. GAMMA Investing LLC increased its holdings in shares of Xylem by 29.1% during the first quarter. GAMMA Investing LLC now owns 4,241 shares of the industrial products company's stock worth $507,000 after purchasing an additional 956 shares during the period. SG Americas Securities LLC increased its holdings in shares of Xylem by 40.4% during the first quarter. SG Americas Securities LLC now owns 11,604 shares of the industrial products company's stock worth $1,386,000 after purchasing an additional 3,338 shares during the period. CX Institutional bought a new position in shares of Xylem during the first quarter worth approximately $245,000. Finally, Simon Quick Advisors LLC bought a new position in shares of Xylem during the first quarter worth approximately $307,000. 87.96% of the stock is owned by institutional investors.
Insiders Place Their Bets
In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm's stock in a transaction that occurred on Friday, September 5th. The shares were sold at an average price of $139.96, for a total value of $139,960.00. Following the sale, the chief accounting officer owned 2,957 shares in the company, valued at $413,861.72. This trade represents a 25.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 0.27% of the stock is owned by corporate insiders.
Xylem Stock Performance
Shares of NYSE:XYL opened at $144.30 on Monday. The company's 50 day simple moving average is $143.08 and its 200 day simple moving average is $130.45. The stock has a market capitalization of $35.12 billion, a price-to-earnings ratio of 37.48, a price-to-earnings-growth ratio of 2.49 and a beta of 1.13. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.90 and a quick ratio of 1.43. Xylem Inc. has a 1 year low of $100.47 and a 1 year high of $151.16.
Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.15 by $0.11. The business had revenue of $2.30 billion for the quarter, compared to analysts' expectations of $2.20 billion. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The firm's quarterly revenue was up 6.1% compared to the same quarter last year. During the same period last year, the firm posted $1.09 earnings per share. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. As a group, research analysts predict that Xylem Inc. will post 4.65 EPS for the current fiscal year.
Xylem Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th were given a $0.40 dividend. The ex-dividend date was Thursday, August 28th. This represents a $1.60 dividend on an annualized basis and a yield of 1.1%. Xylem's dividend payout ratio (DPR) is currently 41.56%.
Analyst Ratings Changes
Several brokerages have recently commented on XYL. Weiss Ratings reaffirmed a "buy (b)" rating on shares of Xylem in a report on Wednesday, October 8th. Barclays began coverage on shares of Xylem in a report on Friday, September 19th. They set an "overweight" rating and a $165.00 target price on the stock. Wall Street Zen raised shares of Xylem from a "hold" rating to a "buy" rating in a report on Saturday, August 9th. TD Cowen raised their target price on shares of Xylem from $125.00 to $130.00 and gave the stock a "hold" rating in a report on Tuesday, August 26th. Finally, Citigroup raised their target price on shares of Xylem from $168.00 to $173.00 and gave the stock a "buy" rating in a report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have given a Hold rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $154.67.
Get Our Latest Stock Analysis on Xylem
About Xylem
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.